Planned sale

Sophia Genetics (SOPH): Officer filed to sell ~$181K

PHILIPPE MENU, Officer at Sophia Genetics, filed to sell ~$181K of Sophia Genetics shares.

~$181K
planned to sell · 22K shares, around Oct 5, 2026
Planned for
Oct 5, 2026
Notice filed
Oct 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Oct 12, 2026Insider · 2 peopleInsiders: 2 sales (~$98K)
    2. Oct 13, 2026InsiderOfficer sold ~$29K of SOPH shares in the open market
    3. Nov 6, 2026Insider · 2 peopleInsiders: 2 purchases (~$278K)
    4. Nov 9, 2026InsiderOfficer sold ~$10K of SOPH shares in the open market
    5. Nov 10, 2026Insider · 2 peopleInsiders: 2 sales (~$114K)
    6. Nov 12, 20265% stakeSchindel Yair Chaim filed an activist stake (13D) of 6.2%
    View the official recordSEC Form 144

    How to read SEC Form 144

    Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

    Full guide: What is an SEC Form 144?

    What else is on file for Sophia Genetics

    For Sophia Genetics, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SOPH page.

    How this filing works

    Explore the data

    Other disclosures at Sophia Genetics

    Everything OQRO holds on this company is on its SOPH page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data